Meu SciELO
Serviços Personalizados
Journal
Artigo
Indicadores
Citado por SciELO
Acessos
Links relacionados
Citado por Google
Similares em SciELO
Similares em Google
Compartilhar
Anales de Medicina Interna
versão impressa ISSN 0212-7199
Resumo
IGLESIA MARTINEZ, F. de la et al. Follow up relevance in the secondary prevention of ischemic heart disease with atorvastatin: Pilot study. An. Med. Interna (Madrid) [online]. 2002, vol.19, n.1, pp.11-15. ISSN 0212-7199.
Objective: To determine the usefulness of different intensities of follow up when atorvastatin is used in the secondary prevention of ischemic heart disease. Material and methods: Design. Prospective study with balanced randomized allocation including a concurrent control group. Setting: Ambulatory care. Patients: 75 patients hospitalized because of acute coronary syndromes were administered atorvastatin as secondary prevention of ischemic heart disease and randomized either to intensive folow up or to a control visit 6 months apart. Interventions: The intensive folow up group (40 patients) was controlled every 2 months as outpatients and a physical examen and lipid profile was done, enhancing diet and exercise and adjusting the statin dose. The control group was evaluated just once after a 6 six month period. Results: 88% were males and the average age was 63.7 ± 10 year. Basal characteristics, myocardial infarction, revascularized procedures and initial chemistry and lipid profile were similar in both groups, although there was a higher proportion of patients in the control group taking ACE. After 6 months total cholesterol, LDL colesterol and triglycerides reduction was higher in the intensive follow up group (33 vs. 24, 34 vs. 26 y 51 vs. 24 mg/dl, respectively) without realising statistical significance. Hospital readmissions were lesser in the intensive group (7.3% vs. 19.4%, P = 0.114). There was one death in each group. Conclusions: Results show a tendency indicating that follow up planification is relevant to obtein the target lipid level recomen in the secondary prevention.
Palavras-chave : Ischemic heart disease; Secondary prevention; Follow up planification.